Patents
Patents for C07C 69 - Esters of carboxylic acids; Esters of carbonic or haloformic acids (54,756)
03/2005
03/15/2005US6867314 Acylating betulin to betulin 3,28-dibenzoate, which is alcoholyzed to betulin-3-acetate, which is oxidized to betulinic aldehyde-3-acetate, which is oxidized to betulinic acid-3-acetate which is then deprotected
03/15/2005US6867298 Group IB compounds used as condensation, amination, amidation or arylation catalysts; catalysis; efficiency
03/15/2005US6867218 An arylene or heteroarylene alkoxy or hydroxy-propionic acid or ester derivatives; treatment or prevention of Peroxisome Proliferator-Activated Receptors; diabetes, impaired glucose tolerance, insulin resistance or obesity
03/15/2005US6867171 Liquids; easy to handle; paper chemicals, lubricants, dis-persants, detergents
03/15/2005US6867164 Catalyst for production of acetic acid or acetic acid and ethyl acetate, process for its production and process for production of acetic acid or acetic acid and ethyl acetate using it
03/10/2005WO2005021482A1 Improvements in or relating to phthalate plasticiser esters
03/10/2005WO2005021479A1 Benzotropolone derivatives and modulation of inflammatory response
03/10/2005WO2005021465A1 Method for producing aromatic unsaturated compound
03/10/2005US20050055551 Interactive protocol for remote management of access control to scrambled data
03/10/2005US20050054886 Fluorinating 2,3,5,6-tetrachloroterephthalonitrile to obtain 2,3,5,6-tetrafluoroterephthalonitrile, hydrogenating to form 1,4-bis(aminomethyl)-2,3,5,6-tetrafluorobenzene, converting 1,4-bis(aminomethyl)-2,3,5,6-tetrafluorobenzene to 1,4-bis(hydroxymethyl)-2,3,5,6-tetrafluorobenzene, then halogenating
03/10/2005US20050054877 Enantiomerically selective cyclopropanation
03/10/2005US20050054759 Thermoplastic elastomer compositions containing a phase change solvent and selected processing oils
03/10/2005US20050054671 Derivatives of alpha-phenylthiocarboxylic and $g(a)-phenyloxy-carboxylic acids useful for the treatment of diseases responding to pparalpha activation
03/10/2005US20050054632 Naphthyl compounds, intermediates, compositions, and methods of use
03/10/2005US20050054538 Novel compounds
03/10/2005US20050053208 Process, arrangement, devices for seizure of a shared telephone line
03/10/2005CA2536842A1 Benzotropolone derivatives and modulation of inflammatory response
03/10/2005CA2535265A1 Compositions and methods for the treatment of disease associated with trp-p8 expression
03/09/2005EP1512704A1 High refractive index, UV-curable monomers and coating compositions prepared therefrom
03/09/2005EP1512674A1 Fluoropolymer composition with organoonium and blocked oxalate compounds
03/09/2005EP1511736A1 Therapeutic molecules and methods-1
03/09/2005EP1511729A1 Histone deacetylase inhibitors based on alphachalcogenmethylcarbonyl compounds
03/09/2005EP1511722A1 Phenylcyclohexylpropanolamine derivatives, preparation and therapeutic application thereof
03/09/2005EP1511716A2 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
03/09/2005EP1511714A1 Cosmetic and/or pharmaceutical preparations comprising retinol esters
03/09/2005EP1511713A2 Compounds that abrogate dna-damage-induced cell cycle g2 checkpoint and/or augment the anti-cancer activity of dna-damaging treatments
03/09/2005EP1511712A1 Process for the production of aliphatic carboxylic acid esters
03/09/2005EP1511710A1 Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer s disease, type 2 diabetes, and parkinson s disease
03/09/2005EP1436304B1 Novel disphospines, their complexes with transition metals and their use in asymmetric synthesis
03/09/2005EP1254881B1 Process for producing aryl ether
03/09/2005EP1137429B1 Cherry extracts for inhibiting cyclooxygenase enzymes
03/09/2005CN1592765A Nobonene-ester based addition polymer and method for preparing the same
03/09/2005CN1592733A Method for the production of alicyclic polycarboxylic acid esters from partial esters of aromatic polycarboxylic acids
03/09/2005CN1592303A Methods and systems for application instance level workload distribution affinities
03/09/2005CN1592175A Method for producing long code mask for cluster service
03/09/2005CN1592106A Adapting device capable of converting picture element clock pulse into character clock pulse
03/09/2005CN1591513A Method and device for connecting sensors or actuators to a bus system
03/09/2005CN1590555A Hydroxylation of compactin to pravastatin by micromonospora
03/09/2005CN1590523A Method of producing a fatty acid ester
03/09/2005CN1590372A Arylphenyl-substituted cyclic ketoenols
03/09/2005CN1590363A Crystallized pravastatin sodium salt and its preparing process
03/09/2005CN1590362A Method of separating metallic catalyst constituents from reaction mixtures
03/09/2005CN1590361A Methods, systems and catalysts for esterification, esters made thereby and downstream products made from the esters
03/09/2005CN1590357A Lightfast additive having uv-absorbing moiety and ink composition including the same
03/09/2005CN1192010C Vapor phase carbonylation process using promoted iridium catalyst
03/08/2005US6864394 Method for producing ketones from carboxylic acid anhydrides
03/08/2005US6864390 Antiepileptic agents; central nervous system disorders; psychological disorders
03/08/2005US6864386 Fluorinated compounds
03/08/2005US6864374 Synthesis of r(+)α-lipoic acid
03/08/2005US6864291 Agonists specific for the peripheral cannabinoid receptor
03/08/2005US6864287 Cardiovascular disorders; hypotensive agents
03/08/2005US6863211 Omega-hydrofluoroalkyl ethers, precursor carboxylic acids and derivatives thereof, and their preparation and application
03/03/2005WO2005020616A1 Method for selection of an available transmission channel by sending a negative decision value and an additional positive decision value and corresponding base station mobile terminal and mobile radio network
03/03/2005WO2005019156A2 Biphenyl-4-carboxylic acid alkyloxycarbonyl phenyl esters and uses thereof
03/03/2005WO2005019155A1 Process for the preparation of 1,2,6,7,8,8a-hexahydro-beta,delta,6-trihydroxy-2-methyl-8-[(2s)-2-methyl-1-oxobutoxy]-, (beta r,delta r,1s,2s,6s,8s,8ar)-1-naphthaleneheptanoic acid, sodium salt.
03/03/2005WO2005019147A2 Pesticidally active phenol derivatives
03/03/2005WO2005019140A1 Ethyl 4-(2-tert-butoxy-2-oxoethyl)-2-ethoxybenzoate, intermediate for the preparation of repaglinide
03/03/2005WO2005018632A1 Treatment of neurodegenerative conditions
03/03/2005WO2003089418A8 Indane acetic acid derivatives and their use as pharmaceutical agents
03/03/2005US20050050202 Methods, systems and computer program products for application instance level workload distribution affinities
03/03/2005US20050049422 New salts of HMG-CoA reductase inhibitors
03/03/2005US20050049417 Metathesis catalysts
03/03/2005US20050049376 High refractive index, uv-curable monomers and coating compositions prepared therefrom
03/03/2005US20050049284 therapeutic and preventive agents for scavenging free radicals and for inflammatory conditions; show a high safety even in a long-term administration and used as part of food, beverage and/or cosmetic products that are used daily; Neotheaflavate B; EGCGCa ( Epigallocatechinocatechol gallate )
03/03/2005US20050049227 Cyclohexyl prostaglandin analogs as EP4-receptor agonists
03/03/2005US20050048091 Branched ester composition
03/03/2005US20050046600 Robust system for transmitting and receiving map data
03/03/2005DE102004038068A1 Verfahren zur Erzeugung eines Fettsäureesters A method for producing a fatty acid ester
03/03/2005CA2527953A1 Process for preparing 3-aryl-2-hydroxy propanoic acid derivatives without resolution
03/02/2005EP1509492A2 Short-acting sedative hypnotic agents for anesthesia and sedation
03/02/2005EP1509188A2 Compounds active at the glucocorticoid receptor ii
03/02/2005EP1179189B1 Process for the preparation of an mr contrast agent
03/02/2005EP0991636B1 Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities
03/02/2005CN1589556A Digital implementation of multi-channel demodulators
03/02/2005CN1589254A Double esters
03/02/2005CN1588851A Biological identifying device and method for proofing replay attach
03/02/2005CN1587251A Process for preparing chicoric acid from echinacea purpurea
03/02/2005CN1587250A Process for synthesizing cyclohexyl propyl acrylate
03/02/2005CN1587249A Method for reducing impurity diester content in preparing (mechyl) hydroxy alkyl acrylate
03/02/2005CN1191228C Synthesis method of nitroxymethylphenyl esters of aspirin derivatives
03/02/2005CN1191227C Process for preparing butyl butyrate
03/01/2005US6861964 Robust system for transmitting and receiving map data
03/01/2005US6861569 Obtaining diamondoid compositions enhanced in tetramantane components and other higher diamondoid components from a hydrocarbon feedstock; involves distillation and pyrolysis
03/01/2005US6861557 Process for preparing rac-bicalutamide and its intermediates
03/01/2005US6861552 Such as 2-methyl-adamantyl acrylate; storage stability
03/01/2005US6861551 Processes for the preparation of macrocyclic ketones
03/01/2005US6861537 Tricyclic and tetracyclic taxane intermediates
03/01/2005US6861500 Resins curable with actinic energy ray, process for the production thereof, and photocurable and thermosetting resin composition
03/01/2005US6861391 Pesticides and herbicides
03/01/2005US6860926 Diperfluoroalkyl- ester or sulfonamide ester derivatives
02/2005
02/24/2005WO2005016944A1 Novel metathesis catalysts
02/24/2005WO2005016862A1 Substituted arylalkanoic acid derivative and use thereof
02/24/2005WO2004099168A3 Substituted carboxylic acids
02/24/2005US20050043568 Novel acid halide derivatives, their production, and production of indanonecarboxylic acid esters using the same
02/24/2005US20050043565 Methods for producing substituted acrylic acid esters and use of the latter for producing substituted $G (G)-amino acids
02/24/2005US20050043411 Process for preparing homophthalate derivatives
02/24/2005US20050043376 Epothilone A and B; desoxyepothilone A and B; anticancer agenst
02/24/2005US20050043278 administering to a patient a hydroxy compound to treat aging, Alzheimer's Disease, cancer, cardiovascular disease, diabetic nephropathy, diabetic retinopathy, a disorder of glucose metabolism, dyslipidemia, dyslipoproteinemia, hypertension, impotence, inflammation, septicemia and syndrome X
02/24/2005US20050042771 Identifying non-drug targets; use in drug design for improving knowledge of drug-target and drug-non-target interactions, so that drug adverse reactions can be reduced or eliminated in drugs such as troglitazone, rosiglitazone, pioglitazone, methotrexate, atorvastatin, celecoxib, rofecoxib, cerivastatin
02/24/2005US20050040364 Liquid crystalline laterally polymerizable compounds